Company news

CelLBxHealth plc news in 2025

CelLBxHealth plc's news releases, calls and decks from 2025, newest first.

View company

Cellbxhealth PLC Announces Holding(s) in Company

December 23, 2025

PDMR Dealing and ESOT Share Purchase

December 19, 2025

Results of General Meeting and Board Changes

December 15, 2025

Additional Subscription

December 2, 2025

Result of Retail Offer

December 1, 2025

Update to Admission of Fundraising Shares

November 25, 2025

Proposed Placing and Subscription

November 24, 2025

QIAGEN Collaboration and Co-Marketing Agreement

November 18, 2025

CelLBxHealth PLC Presents Proof-of-Concept Study

November 5, 2025

Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding

November 4, 2025

Change of name

October 29, 2025

Appointments: Interim CEO and senior board advisor

October 16, 2025

Strategy Update

October 8, 2025

Presentation of Data on Glioblastoma

September 29, 2025

Board Changes

September 12, 2025

Interim Results

September 9, 2025

Notice of Results

September 5, 2025

ANGLE announces collaboration with Myriad Genetics

August 20, 2025

Parsortix enables study of cancer progression

July 8, 2025

Result of 2025 Annual General Meeting

June 30, 2025

EACR 2025: Innovation in AR expression profiling

June 17, 2025

Novel discoveries into the biology of cancer

June 10, 2025

Posting of annual report and notice of AGM

June 9, 2025

Preliminary Results

May 28, 2025

Results supporting ANGLE’s HER2 assay programme

April 28, 2025

Issue of LTIP Options and Share Options

March 21, 2025

Novel findings using Parsortix

February 6, 2025

Analysis of CTC-DNA and ctDNA using Illumina assay

January 29, 2025

Parsortix used in research paper from ETH Zurich

January 24, 2025

Trading Update

January 23, 2025

Calls in 2025

Decks in 2025